Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Optically Active Alcohol. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN101240299B enables high-purity optically active alcohols via yeast catalysis. Enhances supply chain reliability and reduces manufacturing costs significantly.
Patent CN1819998B details a novel route for epoxy alcohol intermediates, offering significant cost reduction in API manufacturing and enhanced supply chain reliability for global buyers.
Patent CN103408399B offers high-yield reduction. Reliable supplier for pharma intermediates with cost reduction potential.
Patent CN1898193A details a lithium-catalyzed method for producing bisamido alcohols, offering a safer, high-yield alternative to acyl chloride routes for asymmetric catalyst ligands.
Patent CN116323522B reveals a base-free ruthenium catalyst enabling stable, scalable production of optically active secondary alcohols with superior cost efficiency.
Patent CN1926083B details a novel ruthenium-catalyzed asymmetric hydrogenation method for producing high-purity optically active alcohols with superior stereoselectivity and yield.
High-yield asymmetric hydrogenation patent CN1926083B enables cost-effective production of chiral alcohols for pharma intermediates with superior enantioselectivity.
Discover CN101983186B technology for asymmetric hydrogenation. Enables cost reduction in pharmaceutical intermediate manufacturing with high stereoselectivity.